Form 8-K - Current report:
SEC Accession No. 0001104659-25-090113
Filing Date
2025-09-16
Accepted
2025-09-15 19:50:02
Documents
12
Period of Report
2025-09-11
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2526167d1_8k.htm   iXBRL 8-K 29055
  Complete submission text file 0001104659-25-090113.txt   194270

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ocgn-20250911.xsd EX-101.SCH 3008
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocgn-20250911_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocgn-20250911_pre.xml EX-101.PRE 22354
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2526167d1_8k_htm.xml XML 3554
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36751 | Film No.: 251315451
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)